Literature DB >> 8117345

Antioxidant vitamins and coronary heart disease.

D Steinberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8117345     DOI： 10.1056/NEJM199305203282012

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

Review 1.  Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.

Authors:  Mehdi H Shishehbor; Stanley L Hazen
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

Review 2.  Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants.

Authors:  Yan-Jun Xu; Paramjit S Tappia; Nirankar S Neki; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

3.  Evidence for a recommended dietary allowance for vitamin C from pharmacokinetics: a comment and analysis.

Authors:  V R Young
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Antioxidant nutrients, atherosclerosis, and coronary heart disease.

Authors:  M F Oliver
Journal:  Br Heart J       Date:  1995-04

Review 5.  Dietary antioxidants, cancer, and atherosclerotic heart disease.

Authors:  D L Tribble; E Frank
Journal:  West J Med       Date:  1994-12

Review 6.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

7.  Do antioxidant vitamins reduce infarct size following acute myocardial ischemia/reperfusion?

Authors:  S D Bellows; S L Hale; B Z Simkhovich; G L Kay; R A Kloner
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

Review 8.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02

9.  Randomized, controlled trial of antioxidant vitamins and cardioprotective diet on hyperlipidemia, oxidative stress, and development of experimental atherosclerosis: the diet and antioxidant trial on atherosclerosis (DATA).

Authors:  R B Singh; A M Niaz; S Ghosh; P Agarwal; S Ahmad; R Begum; Z Onouchi; F A Kummerow
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

10.  Antihyperlipidaemic activity of swertiamarin, a secoiridoid glycoside in poloxamer-407-induced hyperlipidaemic rats.

Authors:  Hitesh Vaidya; Mandapati Rajani; Vasudevan Sudarsanam; Harish Padh; Ramesh Goyal
Journal:  J Nat Med       Date:  2009-07-25       Impact factor: 2.343
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.